In a bilateral tumor mouse model in which only one of the tumors received treatment, the NK + anti‐NKG2A/Qa‐1b injections led to a significant delay in tumor growth in both treated and untreated tumors (Fig 6A) with an increase in the survival levels when compared to control mice (Fig 6B). The gene discussed is KLRC1; the disease is neoplasm.